The influence of glatiramer acetate on dendritic cells mediated Th17-immune response in multiple sclerosis.

被引：0
|
作者：
Sharanova, S. [1 ]
Melnikov, M. [1 ]
Rogovskii, V. [2 ]
Sviridova, A. [3 ]
Boyko, A. [3 ]
Pashenkov, M. [4 ]
机构：
[1] Pirogov Russian Natl Res Med Univ, Dept Neurol Neurosurg & Med Genet, Moscow, Russia
[2] Pirogov Russian Natl Res Med Univ, Dept Mol Pharmacol & Radiobiol, Moscow, Russia
[3] Fed Ctr Cerebrovasc Pathol & Stroke, Dept Neuroimmunol, Moscow, Russia
[4] Inst Immunol, Lab Clin Immunol, Moscow, Russia
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3086
引用
收藏
页码：469 / 469
页数：1
相关论文
共 50 条
  • [41] Multiple sclerosis: Phenotype of cerebrospinal fluid T cells specific for glatiramer acetate
    Hestvik, Anne Lise K.
    Skorstad, Gjertrud
    Vartdal, Frode
    Holmoy, Trygve
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 65 (06) : 599 - 599
  • [42] Patterns of Th1/Th2 Cytokines Predict Clinical Response in Multiple Sclerosis Patients Treated with Glatiramer Acetate
    Tumani, Hayrettin
    Kassubek, Jan
    Hijazi, Mohammed
    Lehmensiek, Vera
    Unrath, Alexander
    Suessmuth, Sigurd
    Lauda, Florian
    Kapfer, Tamara
    Fang, Lubin
    Senel, Makbule
    Brettschneider, Johannes
    EUROPEAN NEUROLOGY, 2011, 65 (03) : 164 - 169
  • [43] Acetate correlates with disability and immune response in multiple sclerosis
    Perez-Perez, Silvia
    Inmaculada Dominguez-Mozo, Maria
    Alonso-Gomez, Aitana
    Medina, Silvia
    Villarrubia, Noelia
    Ignacio Fernandez-Velasco, Jose
    Angel Garcia-Martinez, Maria
    Garcia-Calvo, Estefania
    Estevez, Hector
    Costa-Frossard, Lucienne
    Alvarez-Cermeno, Jose C.
    Luque-Garcia, Jose L.
    Arroyo, Rafael
    Villar, Luisa M.
    Alvarez-Lafuente, Roberto
    PEERJ, 2020, 8
  • [44] Free fatty acids sensitize dermal cells to amplify TH1/TH17-immune responses
    Herbert, D.
    Stelzner, K.
    Popkova, Y.
    Lorz, A.
    Schiller, J.
    Simon, J. C.
    Saalbach, A.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 5 - 5
  • [45] Potential biomarkers of clinical response to interferon-beta and glatiramer acetate in multiple sclerosis
    Dhib-Jalbut, S
    MULTIPLE SCLEROSIS, 2005, 11 : S11 - S11
  • [46] Predictive Biomarkers of Clinical Response to Glatiramer Acetate (GA) Therapy in Multiple Sclerosis (MS)
    Valenzuela, Reuben Mari
    Kaufman, Michael D.
    Russo, Priscilla C.
    Picone, Mary Anne
    Halper, June
    Costello, Kathy
    Rosario, Yaritza M.
    Balashov, Konstantin
    Ito, Kouichi
    Dhib, Suhayl
    NEUROLOGY, 2009, 72 (11) : A469 - A470
  • [47] Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients
    Rio, Jordi
    Rovira, Alex
    Tintore, Mar
    Sastre-Garriga, Jaurne
    Castillo, Joaquin
    Auger, Cristina
    Nos, Carlos
    Comabella, Manuel
    Tur, Carmen
    Vidal, Angela
    Montalban, Xavier
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1602 - 1608
  • [48] SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis
    Hewes, Daniel
    Tatomir, Alexandru
    Kruszewski, Adam M.
    Rao, Gautam
    Tegla, Cosmin A.
    Ciriello, Jonathan
    Vingh Nguyen
    Royal, Walter, III
    Bever, Christopher
    Rus, Violeta
    Rus, Horea
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 102 (02) : 191 - 197
  • [49] Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort
    Santa Rita Pereira, Valeria Coelho
    Malfetano, Fabiola Rachid
    Meira, Isabella D'Andrea
    de Souza, Leticia Fezer
    Liem, Assuncion Martinez
    Maiolino, Angelo
    Alves Leon, Soniza Vieira
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (10) : 774 - 779
  • [50] Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers
    Grossman, Iris
    Avidan, Nili
    Singer, Clara
    Goldstaub, Dan
    Hayardeny, Liat
    Eyal, Eli
    Ben-Asher, Edna
    Paperna, Tamar
    Pe'er, Itsik
    Lancet, Doron
    Beckmann, Jacques S.
    Miller, Ariel
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (08): : 657 - 666
12345